Back to search
Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study was to determine the safety of alpelisib plus fulvestrant in men and post-menopausal women with hormone receptor (HR)-positive, human…
The goal of this observational study is to examine whether markers of PI3K pathway activation are associated with endocrine therapy response and clinicopatholog…